Oncotarget

Retraction:

Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer

PDF  |  How to cite

Oncotarget. 2023; 14:669-669. https://doi.org/10.18632/oncotarget.28439

Metrics: PDF 398 views  |   ?  

Erhong Meng1,3, Lalita A. Shevde1,2 and Rajeev S. Samant1,2

1Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
2Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA
3Beijing DOING Biomedical Technology Co. Ltd., Beijing, China

Published: July 01, 2023

Copyright: © 2023 Meng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: While re-examining this review article published in Oncotarget in 2016, it came to the authors’ attention that significant portions of the text were borrowed verbatim from other publications. Although the borrowed text was properly cited, the authors have concluded that the text in multiple places was not adequately paraphrased or appropriately quoted. In light of this, all authors have agreed to the retraction of this article from Oncotarget.

Original article: Oncotarget. 2016; 7:53984–53996. DOI: https://doi.org/10.18632/oncotarget.9803


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28439